Donation

For more than a decade, the International Myeloma Foundation has attended the American Society of Hematology (ASH) annual meeting, an exciting convergence of thousands of healthcare professionals from around the world. Explore this page to learn about the latest blood cancer research from the meeting, especially key clinical trials to advance the treatment and management of multiple myeloma.

ASH 2023
Prepare for an Intense and Exciting ASH 2023

IMF Chairman Emeritus and Chief Scientific Officer Dr. Brian G.M. Durie gives an overview of what’s to come during this year’s 65th ASH Annual Meeting and Exposition. With more than 7,000 accepted abstracts “representing the most cutting-edge science in hematology,” myeloma scientific content for this year’s ASH will be jampacked in sessions spanning three days. For sessions with overlapping schedules, Dr. Durie advises to use the “teamwork approach” to cover as many abstracts as possible. He makes mention of 2023’s “hot topics”—real-world data, drug access, and racial disparities—and how they will play a major part during this year’s ASH.

b
Image Right
White
Support Group Leaders at 2023 American Society of Hematology meeting
IMF Support Group Leaders Report Live During ASH 2023

Tune in as the IMF brings myeloma support group leaders and patients to the 65th annual meeting of the American Society of Hematology (ASH), “the world’s most comprehensive hematology event of the year.” The IMF thanks these leaders for their care and commitment in sharing their experiences with the global myeloma community. We encourage you to visit the website and follow these leaders for their unique perspectives. 

a
Image Left
White
laptop with streaming video
Your One-Stop Source for ASH Abstract Presentations on Video

Every year at ASH, the IMF films dozens of videos with leading myeloma experts and other Key Opinion Leaders at the American Society of Hematology Annual Meeting & Exposition. This year promises 25+ upcoming videos on some of the most-discussed myeloma-related abstracts from ASH 2023. Click the Learn More button below to explore now.

b
Image Right
White
The iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) team during the 65th American Society of Hematology (ASH) Annual Meeting in San Diego, CA
International Myeloma Foundation and the Black Swan Research Initiative Showcase Six Oral & Poster Abstracts by the iStopMM Project at the 2023 ASH Annual Meeting

The International Myeloma Foundation’s Black Swan Research Initiative® (BSRI) proudly showcased four oral and two poster abstracts from the iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) Project during the 65th American Society of Hematology (ASH) Annual Meeting in San Diego. Also, StopMM team members Thorir Einarsson Long, Jon Thorir Oskarsson, and Sæmundur Rognvaldsson are 2023 ASH Abstract Achievement Awardees. Read the full press release to learn more.

b
Image Left
White
IMF at ASH 2023 Related News and Events

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.